Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Accenture
Harvard Business School
Healthtrust
Federal Trade Commission
Cerilliant
Dow
Chubb
McKesson

Generated: December 16, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NAMENDA XR

« Back to Dashboard

Clinical Trials for Namenda Xr

Trial ID Title Status Sponsor Phase Summary
NCT00120874 Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training Completed Fisher Center for Alzheimer's Research Foundation Phase 4 The purpose of this study is to determine whether a comprehensive, individualized management approach with caregiver training and medication with memantine will alleviate symptoms in community dwelling patients with moderate to severe Alzheimer's disease.
NCT00120874 Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training Completed Forest Laboratories Phase 4 The purpose of this study is to determine whether a comprehensive, individualized management approach with caregiver training and medication with memantine will alleviate symptoms in community dwelling patients with moderate to severe Alzheimer's disease.
NCT00120874 Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training Completed New York University School of Medicine Phase 4 The purpose of this study is to determine whether a comprehensive, individualized management approach with caregiver training and medication with memantine will alleviate symptoms in community dwelling patients with moderate to severe Alzheimer's disease.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Namenda Xr

Condition Name

Condition Name for Namenda Xr
Intervention Trials
Alzheimer's Disease 6
Autism 4
Autism Spectrum Disorder 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Namenda Xr
Intervention Trials
Disease 10
Autistic Disorder 8
Autism Spectrum Disorder 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Namenda Xr

Trials by Country

Trials by Country for Namenda Xr
Location Trials
United States 158
Korea, Republic of 4
Spain 4
Colombia 3
France 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Namenda Xr
Location Trials
New York 14
Massachusetts 13
California 11
Texas 7
Maryland 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Namenda Xr

Clinical Trial Phase

Clinical Trial Phase for Namenda Xr
Clinical Trial Phase Trials
Phase 4 19
Phase 3 5
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Namenda Xr
Clinical Trial Phase Trials
Completed 33
Recruiting 8
Terminated 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Namenda Xr

Sponsor Name

Sponsor Name for Namenda Xr
Sponsor Trials
Forest Laboratories 23
Massachusetts General Hospital 6
University of Rochester 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Namenda Xr
Sponsor Trials
Other 64
Industry 26
NIH 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Deloitte
Queensland Health
Harvard Business School
Chubb
QuintilesIMS
Argus Health
Teva
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.